Treatment Options
Compare Embody's featured treatment paths
These pages are built around the two product decisions Embody puts in front of visitors: weekly semaglutide and weekly tirzepatide. Each page keeps the offer tied to provider review, support expectations, and trust documentation.
Adults looking for a weekly GLP-1 starting point with a simpler medication routine and a clearer provider-guided process.
Review Embody's weekly semaglutide injection path, including what the intake covers, how provider review works, and what to expect before delivery.
- Weekly routine designed for people who want a lower-friction starting path
- Provider-guided review before medication is dispensed
- Keeps the semaglutide decision tied to process, support, and next-step clarity
Adults comparing the stronger tirzepatide-led path and wanting a tighter view of program flow, support, and provider review before they begin.
Explore Embody's weekly tirzepatide path, including how the intake works, what provider review covers, and how the higher-intensity option is framed.
- Weekly dual-pathway option for visitors who already know they want the tirzepatide route
- Clearer separation from the semaglutide offer so intent stays specific
- Connects the product decision to provider review, support, and policy pages